drugset / Trial / NCT01070355

Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases

NCT01070355

Phase 2 Completed 88 enrolled University of Leeds
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Eicosapentaenoic acid (EPA) is a naturally occuring omega-3 polyunsaturated fatty acid found in oily fish. EPA has anti-colorectal (bowel) cancer activity in experimental models. This trial will test whether EPA reduces markers of tumour growth, and is safe and well tolerated,in patients with colorectal cancer liver metastases awaiting surgery.

Timeline

Start
2010-04
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eicosapentaenoic acid Small molecule 2 g Oral

Indications